Literature DB >> 3620276

Comparison of the efficacy and tolerance of isoxicam and piroxicam following surgery for skiing accidents.

P Massart, H Bèzes.   

Abstract

1 A 10 day double-blind study was carried out comparing isoxicam (300 mg day-1) and piroxicam (40 mg day-1 for the first two days and 20 mg day-1 for the remaining days) following surgery in patients who had sustained skiing accidents. There were 20 patients in each group. The isoxicam-treated group had a slightly greater mean pain score prior to treatment. 2 Both isoxicam and piroxicam reduced pain and nocturnal awakening at days 5 and 10, but isoxicam was significantly superior to piroxicam in producing improvement in pain (at day 5, P less than 0.05) and in nocturnal awakenings (at day 10, P less than 0.05). 3 Both agents facilitated rehabilitation and there was no significant difference between them in this regard. 4 All patients in both groups considered themselves 'better' or 'much better' on day 5 of treatment. 5 Both agents were well tolerated by most patients but one patient in each group left the trial because of abdominal pain. One patient stopped isoxicam when she was found to be pregnant.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3620276      PMCID: PMC1400964          DOI: 10.1111/j.1365-2125.1986.tb02999.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

1.  Measurement of pain.

Authors:  E C Huskisson
Journal:  Lancet       Date:  1974-11-09       Impact factor: 79.321

2.  Double blind comparative study of piroxicam and indomethacin in acute locomotor affections linked with sports activity.

Authors:  F Commandre
Journal:  Eur J Rheumatol Inflamm       Date:  1983

3.  Naproxen sodium and piroxicam in acute musculo-skeletal disorders.

Authors:  T A Bouchier-Hayes
Journal:  Br J Sports Med       Date:  1984-06       Impact factor: 13.800

4.  A multicentre comparison of piroxicam and indomethacin in acute soft tissue sports injuries.

Authors:  V Edwards; A A Wilson; H F Harwood; S I Manning; W Brabbin; J W Walker; D G Jones; D V Thomas; R Rimmer; W H Berry
Journal:  J Int Med Res       Date:  1984       Impact factor: 1.671

5.  Multicenter study of piroxicam in the treatment of acute musculoskeletal diseases involving 3011 patients.

Authors:  J L Filho
Journal:  Eur J Rheumatol Inflamm       Date:  1983

6.  Efficacy and safety of piroxicam and indomethacin in the treatment of musculoskeletal disorders. A double blind comparative study.

Authors:  R Günther; D Egg; M Herold
Journal:  Z Rheumatol       Date:  1979 Sep-Oct       Impact factor: 1.372

  6 in total
  1 in total

Review 1.  Single dose piroxicam for acute postoperative pain.

Authors:  J E Edwards; Y K Loke; R A Moore; H J McQuay
Journal:  Cochrane Database Syst Rev       Date:  2000
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.